Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens - Concepedia

Concepedia

Publication | Open Access

Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

DOI Full Paper Access

322

Citations

53

References

2020

Year

Geoffrey M. Lynn, Christine Sedlik, Faezzah Baharom, Yaling Zhu, Ramiro A. Ramirez-Valdez, Vincent Coble, Kennedy K.S. Tobin, Sarah R. Nichols, Yaakov Itzkowitz, Neeha Zaidi,

Nature Biotechnology

VaccinationNanomedicineCross-protectionTumor ImmunologyImmunologyTumor ImmunityTherapeutic VaccineAntigen ProcessingT Cell ImmunityCd4 T Cell ResponsesPeptide–tlr-7/8a Conjugate VaccinesVaccine DesignImmunotherapyMedicineCell Biology

References

	Year	Citations

Page 1

Page 1